title: Survival of women with locally advanced breast cancer at a teaching hospital in Lahore.
abstract: OBJECTIVE
  To correlate the clinical features of women presenting with locally advanced breast cancer with event-free survival (EFS) and overall survival (OS) and to evaluate the patterns of relapse.
  
  
  METHODS
  A total of 200 patients presenting consecutively over 9 years with Stage III breast cancer were evaluated for age, socio-economic status (SES), tumour size and grade, number of involved lymph nodes, stage III sub-categories, estrogen and progesterone receptor (ER/PR) status, treatment profiles and responses, and sites of relapse. EFS and OS at 5 and 10 years were calculated.
  
  
  RESULTS
  Median age was 45 years. Poorly differentiated tumours were found in 127 patients, while 128 had larger tumours (T3 and T4). Eighty women had extensive nodal involvement (N2 and N3), and 86 had Stage IIIA tumours. Chemotherapy was given to 44 patients before surgery and one of these patients achieved pathological complete response. At 5 and 10 years, EFS was 25% and 7%, and OS was 52% and 31%, respectively. By Cox regression analysis, significant predictors of EFS included tumour size (95% CI 1.14-1.72), nodal involvement (95% CI 1.06-1.59) and ER/PR positive tumours (95% CI 1.08-2.29). Predictors of OS included nodal involvement (95% CI 0.98-3.3) and ER/PR positive tumours (95% CI 1.08-2.29). No patient in stage IIIC was alive at 10 years. Loco-regional disease was the most common site of relapse (28.5%).
  
  
  CONCLUSIONS
  Locally advance breast cancer at our centre is associated with poor survival, and most patients relapsed by 5 years.
authors.affiliation: Department of Oncology, Allama Iqbal Medical College, Lahore, Pakistan.
authors.forename: Javaid
authors.initials: J
authors.lastname: Iqbal
authors.forename: Kausar
authors.initials: K
authors.lastname: Bano
authors.forename: Asif
authors.initials: A
authors.lastname: Saeed
authors.forename: Muhammad
authors.initials: M
authors.lastname: Akram
authors.forename: Zeba
authors.initials: Z
authors.lastname: Aziz
mesh_terms: D001943:Breast Neoplasms / Q000401:mortality* / Q000473:pathology* / Q000628:therapy; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006784:Hospitals, Teaching / Q000706:statistics & numerical data; D006801:Humans; D053208:Kaplan-Meier Estimate; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D010154:Pakistan / Q000453:epidemiology; D011379:Prognosis; D012008:Recurrence; D015996:Survival Rate